Status:
NOT_YET_RECRUITING
Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia
Lead Sponsor:
National Health Insurance Service Ilsan Hospital
Conditions:
Pneumonia
Probiotics
Eligibility:
All Genders
19-79 years
Phase:
PHASE4
Brief Summary
The study goal is to determine whether oral administration of a probiotic mixture can reduce the incidence of antibiotic-associated diarrhea in patients with community-acquired pneumonia.
Eligibility Criteria
Inclusion
- Adult patients aged 19 years or older admitted with a diagnosis of community-acquired pneumonia
- Patients eligible for oral medication administration (able to take oral or enteral feeding)
Exclusion
- Sepsis patients
- Patients admitted to the intensive care unit (ICU) following endotracheal intubation
- Elderly patients aged 80 years or older
- Pregnant women
- Patients who have diarrhea at the time of admission
- Patients with a history of using probiotics within 3 months prior to admission
- Patients with a history of using laxatives within 1 week prior to admission
- Patients suspected of being in shock (mean arterial pressure \< 65 mmHg) at the time of admission
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06990568
Start Date
June 1 2025
End Date
December 31 2026
Last Update
May 25 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.